ProfileGDS5678 / 1424883_s_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 111.065399
GSM967853U87-EV human glioblastoma xenograft - Control 211.152799
GSM967854U87-EV human glioblastoma xenograft - Control 311.079299
GSM967855U87-EV human glioblastoma xenograft - Control 410.907299
GSM967856U87-EV human glioblastoma xenograft - Control 511.00299
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 111.103199
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 210.941599
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 311.001299
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.87799
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 111.002299
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 211.080299
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 311.194899
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 411.109499
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 511.200899